Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 3/20 | 0.50 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 4/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | CETP | P11597 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13058704 | 1.00 | TBXAS1 (0.50) | TBXAS1PLA2G10PLA2G2AALDH1A1LMNA | |
| SCHEMBL4748865 | 0.94 | CNR1 (0.53) | TBXAS1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL31421978 | 0.91 | TLR2 (0.50) | PLA2G10PLA2G2ATLR2CETP | |
| SCHEMBL1101589 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE | |
| SCHEMBL9210754 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE | |
| SCHEMBL1092063 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE | |
| SCHEMBL9206562 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE | |
| SCHEMBL1117789 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE | |
| SCHEMBL20714687 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE | |
| SCHEMBL18954214 | 0.88 | ALDH1A1 (0.68) | ALDH1A1LMNATLR2PRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100297156-A1 | ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES | INDUSTRIAL RESEARCH LIMITED (NZ) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297156-A1 | ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES | PIK3CA, PIK3CB, PIK3CG | TBXAS1 624/4885PLA2G10 44/4885PLA2G2A 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.